UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                  Form 10-QSB/A


(Mark one)

[X]  Quarterly  Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the quarterly period ended September 30, 2005

[_]  Transition Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________


Commission File Number: 0-32379


                            American Ammunition, Inc.
--------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)


       California                                        91-2021594
--------------------------------------------------------------------------------
  (State of incorporation)                         (IRS Employer ID Number)


                      3545 NW 71st Street, Miami, FL 33147
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (305) 835-7400
--------------------------------------------------------------------------------
                           (Issuer's telephone number)


-----------------------
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.    YES [X]   NO [_]


State the number of shares outstanding of each of the issuer's classes of common
equity as of the  latest  practicable  date:  As of  September  17,  2007:,  the
Transfer Agent's records indicate that there are 28,372,922 shares  outstanding.
Of  these  shares,  a total of  21,803,335  shares  were  subject  to an  escrow
agreement referenced in later filings.


Transitional Small Business Disclosure Format (check one):    YES [_]  NO [X]






                            American Ammunition, Inc.
             Form 10-QSB/A for the Quarter ended September 30, 2005

                                Table of Contents


                                                                         Page
PART I - FINANCIAL INFORMATION

  ITEM 1 Financial Statements                                              3

  ITEM 2 Management's Discussion and Analysis or Plan of Operation        25

  ITEM 3 Controls and Procedures                                          33


PART II - OTHER INFORMATION

  ITEM 1 Legal Proceedings                                                33

  ITEM 2 Recent Sales of Unregistered Securities and Use of Proceeds      34

  ITEM 3 Defaults Upon Senior Securities                                  34

  ITEM 4 Submission of Matters to a Vote of Security Holders              34

  ITEM 5 Other Information                                                34

  ITEM 6 Exhibits                                                         34


Signatures                                                                35













                         PART I - FINANCIAL INFORMATION

ITEM 1 - Financial Statements

The September 30, 2005  financial  statements  have been restated to account for
the derivative  liability that was incurred in connection  with the common stock
conversion features and the warrants issued with certain notes payable.



                   American Ammunition, Inc. and Subsidiaries
                           Consolidated Balance Sheets
                           September 30, 2005 and 2004
                                   (Unaudited)

                                                                                 (Restated)
                                                                                September 30,     September 30,
                                                                                    2005               2004
                                                                                ------------------ ------------------
                                                                                             
                                     ASSETS
Current Assets
   Cash on hand and in bank                                                     $          107,972 $         658,641
   Accounts receivable - trade, net allowance for
     doubtful accounts of $-0- and $-0-, respectively                                      105,773           255,236
   Inventory                                                                               566,870         1,025,824
   Prepaid interest                                                                        239,112                 -
   Prepaid expenses                                                                         61,684            62,725
                                                                                ------------------ -----------------

     Total Current Assets                                                                1,081,411         2,002,426
                                                                                ------------------ -----------------

Property and Equipment - at cost or contributed value
   Manufacturing equipment                                                               8,096,289         7,623,415
,  Office furniture and fixtures                                                            55,577            82,719
   Leasehold improvements                                                                  190,277           187,397
                                                                                ------------------ -----------------
                                                                                         8,342,143         7,893,531
   Accumulated depreciation                                                             (5,379,112)       (4,595,887)
                                                                                ------------------ -----------------

     Net Property and Equipment                                                          2,993,031         3,297,644
                                                                                ------------------ -----------------


Other Assets
   Prepaid interest                                                                         59,778                 -
   Patents, Trademarks and Noncompetition agreement,
     net of accumulated amortization of approximately $50,543                              225,147                 -
   Loan costs, net of accumulated amortization of approximately $2,620                      21,380                 -
   Deposits and other                                                                       83,660           415,000
                                                                                ------------------ -----------------

     Total Other Assets                                                                    389,965           415,000
                                                                                ------------------ -----------------


TOTAL ASSETS                                                                    $       4,434,407  $       5,715,070
                                                                                =================  =================



                                  - Continued -


                   The accompanying notes are an integral part
                   of these consolidated financial statements.



                                       3





                   American Ammunition, Inc. and Subsidiaries
                     Consolidated Balance Sheets - Continued
                           September 30, 2005 and 2004
                                   (Unaudited)

                                                                                 (Restated)
                                                                                September 30,     September 30,
                                                                                    2005               2004
                                                                                ------------------ ------------------
                                                                                             
                      LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
   Current maturities of leases payable                                         $                - $              525
   Customer deposits                                                                       201,890            220,006
   Accounts payable - trade                                                                957,487            665,077
   Working capital advance                                                                       -             74,000
   Other accrued liabilities                                                               186,792             82,866
                                                                                ------------------ ------------------

     Total Current Liabilities                                                           1,346,169          1,042,474

Long-Term Liabilities
     Loans from Shareholders                                                               650,000                  -
     Convertible debenture                                                                 241,365            266,365
     Derivative liabilities from note conversion factors                                   308,847                  -
                                                                                ------------------ ------------------

     Total Liabilities                                                                   2,546,381          1,308,839
                                                                                ------------------ ------------------


Commitments and Contingencies


Stockholders' Equity
   Preferred stock - $0.001 par value
     20,000,000 shares authorized.
     1,795,320 shares allocated to Series A
       12,000 shares issued and outstanding                                                     12                 12
     1,000,000 shares allocated to Series B
       91,700 shares issued and outstanding                                                     92                 92
     1,905,882 shares allocated to Series C
       1,905,882 and -0- shares issued and outstanding, respectively                         1,906                  -
   Common stock - $0.001 par value.
     300,000,000 shares authorized.
     76,626,631 and 73,686,672 shares issued and outstanding                                76,627             73,687
   Additional paid-in capital                                                           25,011,948         23,616,708
   Accumulated other comprehensive income                                                   33,279                  -
   Accumulated deficit                                                                 (23,197,445)       (19,009,268)
                                                                                ------------------ ------------------
                                                                                         1,926,419          4,681,231
   Stock subscription receivable                                                           (38,393)          (275,000)
                                                                                ------------------ ------------------

   Total Stockholders' Equity                                                            1,888,026          4,406,231
                                                                                ------------------ ------------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                      $        4,434,407 $       5,715,070
                                                                                ================== =================



                   The accompanying notes are an integral part
                   of these consolidated financial statements.



                                       4





                   American Ammunition, Inc. and Subsidiaries
      Consolidated Statements of Operations and Comprehensive Income (Loss)
             Nine and Three months ended September 30, 2005 and 2004

                                   (Unaudited)

                                                 (Restated)                      (Restated)
                                                 Nine months     Nine months    Three months    Three months
                                                    ended           ended           ended          ended
                                                September 30,   September 30,   September 30,   September 30,
                                                     2005            2004           2005            2004
                                                -------------   -------------   -------------   -------------
                                                                                    
Revenues                                        $   2,233,336   $   1,712,280   $     378,326   $     861,988
                                                -------------   -------------   -------------   -------------
Cost of Sales
   Materials, Direct Labor
      and other direct costs                        3,447,036       1,911,210         944,194         308,503
   Depreciation                                       573,466         523,815         191,155         176,304
                                                -------------   -------------   -------------   -------------
      Total Cost of Sales                           4,020,502       2,435,025       1,135,349         484,807
                                                -------------   -------------   -------------   -------------
Gross Profit                                       (1,787,166)       (722,745)       (757,023)        377,181
                                                -------------   -------------   -------------   -------------

Operating Expenses
   Research and development expenses                    2,615           8,332             804           1,858
   Marketing and promotion expenses                   161,502         368,458          49,750         114,404
   Other operating expenses                           910,423         845,663         278,902         250,570
   Bad debt expense                                         -          27,819               -               -
   Interest expense                                    69,875          15,825          55,181              58
   Depreciation and amortization                       45,305           5,681          15,102           1,894
   Consulting expense related to
      common stock issuances at less
      than "fair value"                               198,000         356,000               -               -
                                                -------------   -------------   -------------   -------------
      Total Operating Expenses                      1,377,720       1,627,778         399,739         368,784
                                                -------------   -------------   -------------   -------------

Loss from Operations                               (3,174,886)     (2,350,523)     (1,156,089)          8,397
Other Income (Expense)
   Interest and other income                            8,146           1,409           1,914           1,155
                                                -------------   -------------   -------------   -------------
Loss before Income Taxes                           (3,166,740)     (2,349,114)     (1,154,848)          9,552
Provision for Income Taxes                                  -               -               -               -
                                                -------------   -------------   -------------   -------------
Net Loss                                           (3,166,740)     (2,349,114)     (1,154,848)          9,552
Other Comprehensive Income
   Change in derivative related to
      note conversion                                  33,279               -          32,496               -
                                                -------------   -------------   -------------   -------------
Comprehensive Loss                              $  (3,133,461)  $  (2,349,114)  $  (1,122,352)  $       9,552
                                                =============   =============   =============   =============

Net Loss                                        $  (3,166,740)  $  (2,349,114)  $  (1,154,848)  $       9,552
Preferred Stock dividends                             (40,830)        (31,110)        (13,610)        (10,370)
                                                -------------   -------------   -------------   -------------
Net Loss available to
   Common Shareholders                          $  (3,207,570)  $  (2,380,224)  $  (1,141,238)  $        (818)
                                                =============   =============   =============   =============
Loss per weighted-average share of
   common stock outstanding, computed
   on net loss - basic and fully diluted        $       (0.04)  $       (0.03)  $       (0.01)  $        0.00
                                                =============   =============   =============   =============
Weighted-average number of
   common shares outstanding                       75,358,091      70,873,791      76,241,380      73,673,416
                                                =============   =============   =============   =============



                   The accompanying notes are an integral part
                   of these consolidated financial statements.



                                       5





                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                  Nine months ended September 30, 2005 and 2004
                                   (Unaudited)

                                                                                 (Restated)
                                                                                 Nine months        Nine months
                                                                                    ended              ended
                                                                                September 30,      September 30,
                                                                                    2005                 2004
                                                                                -------------      -------------
                                                                                             
Cash flows from operating activities
   Net loss for the year                                                        $  (3,166,740)     $  (2,349,114)
   Adjustments to reconcile net loss to
     net cash provided by operating activities
       Depreciation and amortization                                                  664,626            529,496
       Bad debt expense                                                                     -             27,819
       Compensation expense related to common stock
         issuances at less than "fair value"                                          198,000            356,000
       Common stock issued for fees and services                                       17,333             90,160
       (Increase) Decrease in
         Accounts receivable                                                          533,671            237,780
         Inventory                                                                    345,554             86,932
         Prepaid expenses, deposits and other                                          (2,838)           (28,137)
       Increase (Decrease) in
         Accounts payable - trade                                                     (29,398)            36,213
         Other accrued expenses                                                        15,773             69,445
         Customer deposits                                                           (239,016)           215,906
                                                                                -------------      -------------
Net cash used in operating activities                                              (1,663,035)          (727,500)
                                                                                -------------      -------------
Cash flows from investing activities
   Purchase of property and equipment                                                (111,065)          (436,214)
                                                                                -------------      -------------
Net cash used in investing activities                                                (111,065)          (436,214)
                                                                                -------------      -------------
Cash flows from financing activities
   Funding of working capital advance                                                       -             74,000
   Principal paid on long-term capital leases                                               -             (7,316)
   Cash paid to obtain capital                                                        (10,000)                 -
   Cash received loans from shareholders                                              650,000                  -
   Cash received on sale of common stock                                              436,607          1,250,000
                                                                                -------------      -------------
Net cash provided by financing activities                                           1,076,607          1,316,684
                                                                                -------------      -------------

Increase (Decrease) in Cash                                                          (697,493)           152,970

Cash at beginning of year                                                             805,465            505,671
                                                                                -------------      -------------
Cash at end of year                                                             $     107,972      $     658,641
                                                                                =============      =============



                                  - Continued -

                                       6





                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                  Nine months ended September 30, 2005 and 2004

                                   (Unaudited)

                                                                                 (Restated)
                                                                                 Nine months        Nine months
                                                                                    ended              ended
                                                                                September 30,      September 30,
                                                                                    2005                 2004
                                                                                -------------      -------------
                                                                                             
Supplemental disclosure of interest
   and income taxes paid
     Interest paid for the period                                               $      10,753      $        825
                                                                                =============      =============
     Income taxes paid for the period                                           $           -      $           -
                                                                                =============      =============

Supplemental disclosure of non-cash investing and financing activities
     Asset purchase agreement for equipment, inventory and
       intellectual property accrued as a component of accounts payable         $           -      $     500,000
                                                                                =============      =============
     Common stock issued for payment of loan costs                              $      24,000      $           -
                                                                                =============      =============






















                   The accompanying notes are an integral part
                   of these consolidated financial statements.



                                       7




                   American Ammunition, Inc. and Subsidiaries
                   Notes to Consolidated Financial Statements
                           September 30, 2005 and 2004


Note A - Organization and Description of Business

American Ammunition,  Inc. (AAI or Company) was incorporated on February 1, 2000
in accordance with the Laws of the State of California. The Company functions as
a holding company providing  management  oversight  services to its wholly-owned
operating  subsidiaries;  F&F Equipment,  Inc. and Industrial Plating Enterprise
Co.

F&F Equipment,  Inc.(F&F) was incorporated on October 4, 1983 in accordance with
the Laws of the State of Florida. F&F is engaged in the design,  manufacture and
international  sales of small arms  ammunition.  F&F has  conducted its business
operations under the assumed name of "American Ammunition" since its inception.

Industrial  Plating  Enterprise Co. (IPE),  which was incorporated and commenced
production on June 14, 2002.  IPE is a fully  licensed and approved state of the
art electrochemical  metallization facility for processing the Company's line of
small arms  projectiles as well as other  products and services while  employing
environmentally  sound water conservation and proven waste treatment techniques.
The facility meets or exceeds all current environmental  requirements and enjoys
the "conditionally exempt small quantity generator" status for State and Federal
regulations.  All  activities of IPE since its inception  have been dedicated to
the needs and demands of F&F.


Note B - Preparation of Financial Statements

The  Company and its  subsidiaries  follow the accrual  basis of  accounting  in
accordance with accounting principles generally accepted in the United States of
America and have adopted a year-end of December 31 for all entities.

The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  management to make
estimates  and  assumptions  that  affect  the  reported  amounts  of assets and
liabilities  and disclosure of contingent  assets and liabilities at the date of
the  financial  statements  and the  reported  amounts of revenues  and expenses
during the reporting period. Actual results could differ from those estimates.

Management further acknowledges that it is solely responsible for adopting sound
accounting  practices,   establishing  and  maintaining  a  system  of  internal
accounting  control and preventing and detecting  fraud. The Company's system of
internal  accounting  control is designed to assure,  among other items, that 1)
recorded  transactions  are valid; 2) valid  transactions  are recorded;  and 3)
transactions  are  recorded in the proper  period in a timely  manner to produce
financial  statements which present fairly the financial  condition,  results of
operations  and cash  flows of the  Company  for the  respective  periods  being
presented

During interim periods, the Company follows the accounting policies set forth in
its annual  audited  financial  statements  filed with the U. S.  Securities and
Exchange  Commission  on its  Annual  Report on Form  10-KSB  for the year ended
December 31, 2004.  The  information  presented  within these interim  financial
statements  may not  include all  disclosures  required  by  generally  accepted
accounting  principles  and the  users of  financial  information  provided  for
interim periods should refer to the annual  financial  information and footnotes
when reviewing the interim financial results presented herein.

In the opinion of management,  the accompanying  interim  financial  statements,
prepared in  accordance  with the U. S.  Securities  and  Exchange  Commission's
instructions   for  Form  10-QSB,   are   unaudited  and  contain  all  material
adjustments,  consisting  only of  normal  recurring  adjustments  necessary  to
present fairly the financial condition,  results of operations and cash flows of
the Company for the respective  interim  periods  presented.  The current period
results of operations are not necessarily indicative of results which ultimately
will be reported for the full fiscal year ending December 31, 2005.


                                       8



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note B - Preparation of Financial Statements - Continued

For  segment  reporting  purposes,  the Company  operated  in only one  industry
segment during the periods represented in the accompanying  financial statements
and makes all  operating  decisions and  allocates  resources  based on the best
benefit to the Company as a whole.

The  accompanying  consolidated  financial  statements  contain the  accounts of
American Ammunition, Inc. and its wholly-owned subsidiaries, F&F Equipment, Inc.
and Industrial Plating Enterprise Co. All significant intercompany  transactions
have been eliminated.  The consolidated entities are collectively referred to as
"Company".


Note C - Summary of Significant Accounting Policies

1.   Cash and cash equivalents

     For  Statement of Cash Flows  purposes,  the Company  considers all cash on
     hand  and  in  banks,  certificates  of  deposit  and  other  highly-liquid
     investments with maturities of three months or less, when purchased,  to be
     cash and cash equivalents.

     Cash  overdraft  positions may occur from time to time due to the timing of
     making bank deposits and releasing checks, in accordance with the Company's
     cash management policies.

2.   Accounts receivable and Revenue Recognition

     In the normal course of business,  the Company extends  unsecured credit to
     virtually  all of its  customers  which are located  throughout  the United
     States.  Because of the credit risk  involved,  management  has provided an
     allowance for doubtful accounts which reflects its opinion of amounts which
     will   eventually   become   uncollectible.   In  the  event  of   complete
     non-performance, the maximum exposure to the Company is the recorded amount
     of trade  accounts  receivable  shown on the  balance  sheet at the date of
     non-performance.

     The Company ships all product on an FOB-Plant,  "as-is" basis. Accordingly,
     revenue  is  recognized  by the  Company  at the point at which an order is
     shipped at a fixed price,  collection is reasonably assured and the Company
     has no remaining  performance  obligations related to the sale. The Company
     sells all  products  with "no right of  return"  by the  purchaser  for any
     factor other than defects in the product's production.

     On rare  occasion,  the Company may elect to accept  product  returns  from
     customers on a  case-by-case  basis to offset unpaid  accounts  receivable.
     These  situations  are a "last case"  scenario and are  initiated by senior
     management through negotiations with the respective customer.

3.   Inventory

     Inventory  consists of raw  materials,  work-in-process  and finished goods
     related to the production and sale of small arms  ammunition.  Inventory is
     valued at the lower of cost or market using the first-in, first-out method.

4.   Property, plant and equipment

     Property and  equipment are recorded at  historical  cost.  These costs are
     depreciated over the estimated useful lives of the individual  assets using
     the straight-line method, generally three to ten years.

     Gains and losses from  disposition of property and equipment are recognized
as incurred and are included in operations.


                                       9



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note C - Summary of Significant Accounting Policies - Continued

4.   Property, plant and equipment - continued

     In accordance  with SFAS No. 144, the Company  evaluates  the  accompanying
     financial statements to determine if any impairment  indicators are present
     related  to its fixed  assets and other  long-term  assets.  If  impairment
     indicators  were present,  future cash flows related to the asset group are
     estimated.  The sum of the undiscounted  future cash flows  attributable to
     the  asset  group was then  compared  to the  carrying  amount of the asset
     group.  The  cash  flows  were  estimated   utilizing  various  assumptions
     regarding future revenue and expenses, availability of working capital, and
     proceeds,  if any,  from asset  disposals  on a basis  consistent  with the
     Company's  strategic  plan. If the carrying  amount exceeded the sum of the
     future  undiscounted  future cash flows, the Company  discounted the future
     cash flows  using a risk-free  discount  rate and  recorded  an  impairment
     charge as the difference between the discounted cash flows and the carrying
     value of the asset group.  Generally,  the Company performed its testing of
     the asset group at the overall corporate level, as this is the lowest level
     for  which  identifiable  cash  flows  are  available.  As a result  of the
     impairment  testing  described above,  management is of the opinion that no
     impairment charge is appropriate.

5.   Income Taxes

     The Company uses the asset and liability  method of  accounting  for income
     taxes.  At September 30, 2005 and 2004, the deferred tax asset and deferred
     tax  liability  accounts,  as  recorded  when  material  to  the  financial
     statements,  are entirely the result of  temporary  differences.  Temporary
     differences   represent  differences  in  the  recognition  of  assets  and
     liabilities for tax and financial reporting purposes, primarily accumulated
     depreciation and amortization, allowance for doubtful accounts and vacation
     accruals.

     As of September  30, 2005 and 2004,  the deferred tax asset  related to the
     Company's net  operating  loss  carryforward  is fully  reserved.  If these
     carryforwards  are not  utilized,  they will  begin to expire at the end of
     2005.

6. Earnings (loss) per share

     Basic  earnings  (loss) per share is computed  by  dividing  the net income
     (loss) available to common shareholders by the  weighted-average  number of
     common shares  outstanding  during the respective  period  presented in our
     accompanying financial statements.

     Fully diluted earnings (loss) per share is computed similar to basic income
     (loss) per share  except that the  denominator  is increased to include the
     number of common  stock  equivalents  (primarily  outstanding  options  and
     warrants).

     Common  stock  equivalents  represent  the  dilutive  effect of the assumed
     exercise of the outstanding stock options and warrants,  using the treasury
     stock method, at either the beginning of the respective period presented or
     the date of  issuance,  whichever  is later,  and only if the common  stock
     equivalents  are  considered  dilutive  based upon the Company's net income
     (loss) position at the calculation date.

     As of September 30, 2005 and 2004, and subsequent thereto,  the Company had
     no options outstanding.  The outstanding warrants and convertible preferred
     stock and mandatorily  convertible  debentures are anti-dilutive due to the
     Company's net operating loss position.

7.   Advertising costs

     The Company does not conduct any direct  response  advertising  activities.
     For non-direct response advertising, the Company charges the costs of these
     efforts  to  operations  at the  first  time  the  related  advertising  is
     published.


                                       10



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note C - Summary of Significant Accounting Policies - Continued

7.   Advertising costs

     The Company does not conduct any direct  response  advertising  activities.
     For non-direct response advertising, the Company charges the costs of these
     efforts  to  operations  at the  first  time  the  related  advertising  is
     published.


Note D - Correction of an Error

On August 22, 2007,  our  management  concluded  that the  financial  statements
included in our Forms 10-QSB for June and September 2005, the calendar year 2006
and for the period  ending March 31, 2007,  and the Forms 10-KSB for the periods
ending  December  31,  2005  and  December  31,  2006,  all of which  have  been
previously  filed  with  the  Securities  and  Exchange  Commission,  need to be
restated,  due to the  failure  to include  the  beneficial  conversion  feature
discount on unsecured convertible indebtedness.

Management  discovered  such  changes  needed to be made after  consulting  with
Pollard-Kelley  Auditing Services,  our independent registered public accounting
firm  as of  June  26,  2007,  who  have  concurred  with  management  as to the
reexamination of the above mentioned issues.

The Company has entered into certain  notes  payable to  shareholders  and other
affiliated  parties with embedded  conversion  features and warrant issues.  The
appropriate  accounting is governed by EITF 98-5:  "Accounting  for  convertible
securities  with  beneficial  conversion  features  or  contingency   adjustable
conversion"  and  EITF No.  00-27:  "Application  of  issue  No 98-5 to  certain
convertible instruments". Conversion features determined to be beneficial to the
holder are valued at fair value and recorded to additional paid in capital.  The
fair value is determined to be ascribed to the detachable  warrants  issued with
the convertible  debentures  utilizing the  Black-Scholes  method.  Any discount
derived from determining the fair value to the debenture conversion features and
warrants is  amortized  to financing  cost over the life of the  debenture.  The
unamortized  discount, if any, upon the conversion of the debentures is expensed
to financing cost on a pro rata basis.

Debt issues with the variable  conversion features are considered to be embedded
derivatives  and are  accountable in accordance  with FASB 133;  "Accounting for
Derivative  Instruments and Hedging Activities".  The fair value of the embedded
derivative is recorded to derivative liability. This liability is required to be
marked each reporting period. The resulting discount on the debt is amortized to
interest expense over the life of the related debt.


                                       11




                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note D - Correction of an Error - Continued

The errors  discovered by management  relate  directly to the accounting for and
recording various conversion features and warrants as follows:



                                                                Nine months     Three months
                                                                   ended            ended
                                                               September 30,    September 30,
                                                                   2005               2005
                                                               -------------    -------------
                                                                          
Net Loss, as previously reported                               $  (3,123,504)   $  (1,116,175)

Effect of the correction of an error
(Increase) Decrease in Net Loss by financial
 statement line item:
     Operating expenses: Interest expense recognized
       from beneficial conversion discount feature on
       notes payable to shareholders and other affiliates            (43,236)         (38,673)
                                                               -------------    -------------
 Total effect of changes on Loss from Operations and Net Loss        (43,236)         (38,673)
                                                               -------------    -------------
Net Loss, as restated                                          $  (3,166,740)   $  (1,154,848)
                                                               =============    =============
Net loss available to common stockholders,
 as previously reported                                        $  (3,164,334)   $  (1,129,785)

Effect of the correction of an error
   Total effect as shown above                                       (43,236)         (38,673)
                                                               -------------    -------------
Net Loss available to common stockholders, as restated         $  (3,207,570)   $  (1,168,458)
                                                               =============    =============

Earnings per share, as previously reported                     $       (0.03)   $       (0.01)
Total effect of changes                                                (0.01)           (0.01)
                                                               -------------    -------------
Earnings per share, as restated                                $       (0.03)   $       (0.02)
                                                               =============    =============


In  light of the  restatements  to the  financial  statements  disclosed  above,
caused,  in part, by a failure in the Company's  internal control over financing
reporting  due to the  limitations  in the  Company's  accounting  resources  to
identify  and  react  in  a  timely  manner  to   non-routine,   complex  and/or
transactions  originated by other parties on the  Company's  behalf,  as well as
gaining an adequate  understanding  of the disclosure  requirements  relating to
these types of transactions,  we feel that the existing  controls and procedures
were and remain  effective.  Because of said  controls,  which  resulted  in the
review,  discovery and disclosure by amendment of filings to adequately disclose
required information,  management also concludes that by requiring  supplemental
reviews of financing transactions that its existing controls and procedures will
be more effective.







                                       12



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note E - Fair Value of Financial Instruments

The carrying amount of cash,  accounts  receivable,  accounts  payable and notes
payable, as applicable,  approximates fair value due to the short term nature of
these items  and/or the current  interest  rates  payable in relation to current
market conditions.

Interest  rate risk is the risk  that the  Company's  earnings  are  subject  to
fluctuations  in interest  rates on either  investments  or on debt and is fully
dependent  upon  the  volatility  of  these  rates.  The  Company  does  not use
derivative instruments to moderate its exposure to interest rate risk, if any.

Financial  risk  is  the  risk  that  the  Company's  earnings  are  subject  to
fluctuations in interest rates or foreign exchange rates and are fully dependent
upon the  volatility  of  these  rates.  The  company  does  not use  derivative
instruments to moderate its exposure to financial risk, if any.


Note F - Concentrations of Credit Risk

The  Company  maintains  its cash  accounts  in a single  financial  institution
subject  to  insurance   coverage  issued  by  the  Federal  Deposit   Insurance
Corporation  (FDIC).  Under FDIC rules,  the Company  and its  subsidiaries  are
entitled to aggregate  coverage of $100,000 per account type per separate  legal
entity per financial institution.

During the period ended September 30, 2005 and the periods  subsequent  thereto,
respectively,  the  various  operating  companies  maintained  deposits  in this
financial  institution  with credit risk  exposures in excess of statutory  FDIC
coverage.  The  Company  incurred  no  losses  through  September  30,  2005,and
subsequent thereto, as a result of any of these unsecured situations.


Note G - Inventory

As of  September  30,  2005  and  2004,  inventory  consisted  of the  following
components:

                                     September 30,    September 30,
                                         2005            2004
                                     -------------    -------------
         Raw materials               $     434,305    $     231,456
         Work in process                   122,561          515,622
         Finished goods                     10,004          278,746
                                     -------------    -------------
         Totals                      $     566,870    $   1,025,824
                                     =============    =============





                                       13




                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004



Note H - Property and Equipment

Property and equipment consist of the following components:

                                        September 30,  September 30,  Estimated
                                            2005            2004     useful life
                                        -------------  ------------- -----------
   Manufacturing equipment              $   8,096,289  $   7,623,415  3-10 years
   Office furniture and fixtures               55,577         82,719  3- 7 years
   Leasehold improvements                     190,277        187,397  8-20 years
                                        -------------  -------------
                                            8,342,143      7,893,531
   Accumulated depreciation                (5,379,112)    (4,595,887)
                                        -------------  -------------
   Net property and equipment           $   2,963,031  $   3,297,644
                                        =============  =============

Total  depreciation  expense  charged to  operations  for the nine months  ended
September   30,  2005  and  2004  was   approximately   $577,417  and  $529,496,
respectively.

Included in the  accompanying  balance sheet are the  following  fixed assets on
long-term capital leases:

                                                September 30,    September 30,
                                                    2005             2004
                                                -------------    -------------
     Manufacturing equipment                    $           -    $     153,400
     Less accumulated depreciation                          -          (81,364)
                                                -------------    -------------
                                                $           -    $      72,036
                                                =============    =============


Note I - Capital Leases Payable

Capital  leases  payable  consist of the  following as of September 30, 2005 and
2004, respectively:



                                                                September 30,   September 30,
                                                                     2005            2004
                                                                -------------   -------------
                                                                          
Three  capital  leases,  respectively,  payable  to  various
equipment financing companies.  Interest, at March 31, 2002,
ranging  between  11.37% and  14.05%.  Payable in  aggregate
monthly   installments  of  approximately  $935,   including
accrued  interest.  Final maturities occur between September
2004 and December 2004. Collateralized the underlying leased
manufacturing equipment.                                        $           -   $         525

     Less current maturities                                                -            (525)
                                                                -------------   -------------
     Long-term portion                                          $           -   $           -
                                                                =============   =============



                                       14



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note J - Loans from Shareholders



                                                                September 30,   September 30,
                                                                     2005            2004
                                                                -------------   -------------
                                                                          

Notes payable to three  separate  shareholders.  Interest at
8.0%, payable monthly. Principal due at maturity on December
31, 2006.  Shareholder/lender  has the option to convert the
principal  amount  into  common  stock of the Company at the
lesser of 66-2/3% of the  average  closing bid and ask price
on the date of conversion  or $0.07 per share.  Each note is
unsecured.                                                      $     650,000   $           -
                                                                =============   =============



Note K - Convertible Debenture

The Company  entered into a  Securities  Purchase  Agreement  with La Jolla Cove
Investors,  Inc. ("La Jolla") on October 4, 2002 for the sale of (I) $250,000 in
convertible  debentures and (ii) warrants to buy 30,000,000 shares of our common
stock.  On March 13, 2003 and May 6, 2003,  La Jolla  advanced an  aggregate  of
$350,000 to our company which such funding was  allocated  towards the principal
balance of our convertible debentures.

As of September 30, 2005, the outstanding  balance on the convertible  debenture
is  approximately   $241,365  and  we  have  approximately   2,413,650  warrants
outstanding. A recap of the debenture activity is as follows:

                                            Debenture         Warrant
                                          (in dollars)      (in shares)
                                          ------------      -----------
       Initial amount                     $    600,000        6,000,000
       2003 redemptions                       (208,635)      (2,086,350)
       2004 redemptions                       (135,000)      (1,250,000)
       2005 redemptions                        (25,000)        (250,000)
                                          ------------      -----------
  Balances outstanding at March 31, 2005  $    241,365        2,413,650
                                          ============      ===========

The debentures bear interest at 8%, mature on June 30, 2007, and are convertible
into our common stock,  at the selling  stockholder's  option.  The  convertible
debentures are  convertible  into the number of our shares of common stock equal
to the principal amount of the debentures being converted multiplied by 11, less
the product of the conversion  price multiplied by 10 times the dollar amount of
the debenture. The conversion price for the convertible debentures is the lesser
of (I) $1.00 or (ii)  seventy  six  percent of the  average  of the five  lowest
volume weighted  average prices during the twenty (20) trading days prior to the
conversion.  Accordingly, there is in fact no limit on the number of shares into
which the debenture may be converted.

However,  in the event that our market price is less than $.30, we will have the
option to prepay the debenture at 125% rather than have the debenture converted.
In  addition,  the selling  stockholder  is  obligated  to exercise  the warrant
concurrently  with  the  submission  of  a  conversion  notice  by  the  selling
stockholder.  As of June 30, 2005,  the warrant is  exercisable  into  2,413,650
shares of common stock at an exercise price of $1.00 per share.


                                       15



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note K - Convertible Debenture - Continued

In December  2004,  the  Company  entered  into an  addendum to the  convertible
debenture and warrant whereby the Company agreed to the following:

     *    the discount multiplier was reduced from eighty percent to seventy six
          percent;
     *    within five  business  days after this  registration  statement  being
          declared  effective,  La  Jolla is  required  to  submit  a  debenture
          conversion  in the  amount of  $10,000  and every  ten  business  days
          thereafter La Jolla shall submit three additional debenture conversion
          in the amount of $10,000 each;
     *    within five  business  days after this  registration  statement  being
          declared effective, La Jolla shall wire $400,000 to us as a prepayment
          towards the exercise of its warrant; and
     *    immediately  following  the  sale of all  shares  held by La  Jolla in
          connection with the debenture  conversions in the aggregate  amount of
          $40,000,  La Jolla shall wire  $275,000 to us as a prepayment  towards
          the exercise of its warrant and shall submit a debenture conversion in
          the amount of $6,250 on the first business day of each month until the
          debenture is no longer outstanding.

LaJolla has contractually  agreed to restrict its ability to convert or exercise
its  warrants  and  receive  shares of our common  stock such that the number of
shares of common stock held by them and their  affiliates  after such conversion
or exercise does exceed 4.9% of the then issued and outstanding shares of common
stock.

Due to the  contractually  agreed  mandatory  conversion of this Debenture,  the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

As the warrant is  non-detachable  from the Debenture and requires  simultaneous
exercise upon  conversion of the Debenture,  no value was assigned to the issued
warrant.  Upon exercise of the warrant,  the Company will record the issuance of
the  underlying  shares as a new  issuance  of common  stock on the date of each
respective exercise.

On various dates through  December 31, 2003,  the  Debenture  Holder  elected to
convert an aggregate $208,635, through 24 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 4,561,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 2,086,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $2,086,350.








                                       16



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note K - Convertible Debenture - Continued

On various  dates between  January 1, 2004 and December 31, 2004,  the Debenture
Holder   elected  to  convert  an   aggregate   $125,000,   through  6  separate
transactions,  in outstanding  Debenture principal into registered common stock.
This election  caused the Company to issue  4,150,000  shares of common stock to
the  Debenture  Holder.  Additionally,  pursuant  to  the  contract  terms,  the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase  1,250,000  shares of the Company's  common stock for gross proceeds of
$1,250,000.  As of December  31, 2004,  an aggregate of 1,000,000  shares of the
Company's  common  stock have been  issued by the  Company and are being held in
escrow by the Company's  counsel  pending receipt of the final $150,000 from the
Debenture Holder.

Between  January 1, 2005 and June 30,  2005,  the  Debenture  Holder  elected to
convert an aggregate $25,000,  through a separate  transactions,  in outstanding
Debenture  principal  into  registered  common stock.  This election  caused the
Company  to issue  750,000  shares  of  common  stock to the  Debenture  Holder.
Additionally,  pursuant to the contract terms, the Debenture Holder concurrently
exercised a portion of the outstanding Warrant to purchase 250,000 shares of the
Company's common stock for gross proceeds of $250,000.

On May 6, 2005 and June 21,  2005,  the Company  authorized  the  issuance of an
aggregate 14,000,000 shares into the A designated escrow account for the purpose
of  facilitating  future  conversions of the  outstanding  Debenture into common
stock in conjunction with the exercise of the outstanding  Warrants.  Subsequent
to June 30, 2005, the Debenture Holder, in 4 separate  transactions,  was issued
an aggregate  5,824,758  shares for the  conversion  of an aggregate  $40,000 in
Convertible Debenture and the exercise of 400,000 Warrants at an aggregate price
of $400,000.


Note L - Derivative Liability arising from Warrants

The Company  accounts  for debt with  embedded  conversion  features and warrant
issues in accordance with EITF 98-5: "Accounting for convertible securities with
beneficial  conversion features or contingency  adjustable  conversion" and EITF
No. 00-27:  "Application of issue No 98-5 to certain  convertible  instruments".
Conversion features determined to be beneficial to the holder are valued at fair
value and recorded to additional  paid in capital.  The Company  determines  the
fair value to be ascribed to the detachable warrants issued with the convertible
debentures  utilizing  the  Black-Scholes  method.  Any  discount  derived  from
determining the fair value to the debenture  conversion features and warrants is
amortized  to financing  cost over the life of the  debenture.  The  unamortized
discount, if any, upon the conversion of the debentures is expensed to financing
cost on a pro rata basis.

Debt issues with the variable  conversion features are considered to be embedded
derivatives  and are  accountable in accordance  with FASB 133;  "Accounting for
Derivative  Instruments and Hedging Activities".  The fair value of the embedded
derivative is recorded to derivative liability. This liability is required to be
marked each reporting period. The resulting discount on the debt is amortized to
interest expense over the life of the related debt.










                                       17



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note M - Preferred Stock Transactions

Preferred  stock  consists of the  following as of September  30, 2005 and 2004,
respectively:

                                     September 30, 2005    September 30, 2004
                                     ------------------    ------------------
                                      # shares   value      # shares   value
                                     --------- --------    --------- --------
Series A Cumulative
  Convertible Preferred Stock           12,000 $ 60,000       12,000 $ 60,000
Series B Cumulative
  Convertible Preferred Stock           91,700  458,500       91,700  458,500
Series C Convertible
   Preferred Stock                   1,905,882  324,000            -        -
                                     --------- --------    --------- --------
                                     2,009,582 $842,500      103,700 $518,500
                                     ========= ========    ========= ========

Series A Convertible Preferred Stock

In September,  October and November 2001, the Company sold an aggregate  222,600
shares of $5.00 Series A Convertible  Preferred Stock (Series A Preferred Stock)
for total  proceeds  of  approximately  $1,113,000  through a Private  Placement
Memorandum.  The Series A Convertible  Preferred  Stock  provides for cumulative
dividends at a rate of 8.0% per year,  payable  quarterly,  in cash or shares of
the  Company's  common stock at the Company's  election.  Each share of Series A
Preferred  Stock is  convertible  into 11 shares of the  Company's  common stock
initially  at any time  after 6 months  of the  date of issue  and  prior to the
notice of redemption  at the option of the holder,  subject to  adjustments  for
customary  anti-dilution events. In December 2001, at the request of the holders
of the Series A Preferred Stock, the Company and the individual holders modified
the holding period for conversion to allow for conversion in December 2001.

In September 2001, the Company's principal stockholder  converted  approximately
$4,007,327 of unsecured  debt and  approximately  $3,546,273  of cumulative  and
unpaid accrued interest into 1,510,710 shares of Series A Preferred Stock.

In  September  2001, a creditor of the Company  agreed to convert  approximately
$10,000 of trade accounts payable into 2,000 shares of Series A Preferred Stock.

In December 2001,  concurrent with a modification in the holding period prior to
conversion,  certain holders of the Series A Preferred Stock orally notified the
Company of their intent to exercise the conversion  features on 1,749,720 issued
and outstanding  shares of Series A Preferred  Stock into  19,246,920  shares of
common  stock prior to December  31,  2001.  Due to the timing of the  requisite
documentation,  the  clerical  activities  related to this  conversion  were not
completed until February 2002.

In conjunction with the Series A Preferred Stock, certain shares were sold after
the Company's common stock was approved for trading by the National  Association
of Securities  Dealers on the OTC Bulletin  Board in October 2001. The shares of
Series A Preferred  Stock sold  subsequent  to this date had an  equivalent  per
share  value of  common  stock  below  the  ending  quoted  market  price of the


                                       18



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note M - Preferred Stock Transactions - Continued

Series A Convertible Preferred Stock - continued

Company's common stock on their respective issue dates. This difference  created
a Beneficial  Conversion  Feature  Discount of  approximately  $1,207,993.  This
discount was then  amortized  over the unexpired time period between the date of
issue of the eligible shares and the eligible  conversion date, as amended.  All
of the shares sold  subsequent  to the initial  trading  date were  converted in
December  2001  and,  accordingly,  the  approximate  $1,207,993  in  Beneficial
Conversion Feature Discount was fully amortized to operations.

In December 2002, a holder of 5,000 shares of Series A Preferred Stock exercised
his  conversion  rights and converted  these shares of Series A Preferred  Stock
into 55,000 shares of restricted, unregistered common stock.

In January 2003,  three  separate  holders of 9,000 shares of Series A Preferred
Stock exercised their  conversion  rights and converted these shares of Series A
Preferred stock into 99,000 shares of restricted, unregistered common stock.

Series B Convertible Preferred Stock

In May 2003,  the Company  sold an  aggregate  91,700  shares of $5.00  Series B
Convertible  Preferred  Stock (Series B Preferred  Stock) for total  proceeds of
approximately  $458,500 through a separate  Private  Placement  Memorandum.  The
Series B Convertible Preferred Stock provides for cumulative dividends at a rate
of 8.0% per year, payable  quarterly,  in cash or shares of the Company's common
stock at the  Company's  election.  Each  share of Series B  Preferred  Stock is
convertible  into 11 shares of the Company's  common stock initially at any time
after 6 months of the date of issue and prior to the notice of redemption at the
option of the holder, subject to adjustments for customary anti-dilution events.

Series C Convertible Preferred Stock

In November  2004,  the Company sold  1,905,882  shares of Series C  Convertible
Preferred  Stock to an  existing  shareholder  and  officer of the  Company in a
private  transaction  pursuant to Section (4)2 of the Securities Act of 1933 for
gross proceeds of approximately $324,000. No underwriter was used in conjunction
with this transaction.

The Series C  Convertible  Preferred  Stock  provides for dividends at a rate of
4.0% per annum,  to be declared  and paid monthly in either cash or stock at the
discretion of the Company.

Each share of Series C  Preferred  Stock is  convertible  at a rate of $0.18 per
share into  1,800,000  shares of the  Company's  common stock at any time at the
option of the holder, subject to adjustments for customary anti-dilution events.



                                       19



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note N - Common Stock Transactions

Calendar 2004 transactions

During the period from  February  13,  2004  through  June 4, 2004,  the Company
issued  an  aggregate   4,150,000   shares  of  common  stock,   in  5  separate
transactions,  in  exchange  for the  redemption  of  approximately  $125,000 in
outstanding  debenture  balance and  approximately  $1,250,000  in cash from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $356,000 during this time period.

Additionally,  on June 29,  2004,  the Company  issued an  additional  1,000,000
shares of common stock in advance of the exercise of a $25,000 redemption on the
outstanding debenture payable and a $250,000 cash payment on the exercise of the
affiliated  warrant.  As of December 31, 2004, the Company has received $100,000
in cash on the warrant  exercise and has not applied the debt reduction  portion
of this transaction.

In January 2004, the Company  issued 38,038 shares of  restricted,  unregistered
common stock in payment of approximately $10,000 in accrued dividends payable on
the Company's  outstanding Series A and Series B Preferred Stock for the quarter
ended  December 31, 2003. The Company relied upon Section 4(2) of the Securities
Act of 1933, as amended,  for an exemption from registration of these shares and
no underwriter was used in this transaction.

In May 2004, the Company issued 25,260 shares of restricted, unregistered common
stock in payment of  approximately  $9,170 in accrued  dividends  payable on the
Company's  outstanding  Series B Preferred Stock for the quarter ended March 31,
2004.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

On May 26, 2004, the Company  issued 300,000 shares of restricted,  unregistered
common stock to two separate  corporations  in payment and full  satisfaction of
all  amounts  due for  fees  and/or  commissions  due in  conjunction  with  the
Company's  convertible  debenture  financing  transaction.  This transaction was
valued at  approximately  $36,000,  which was less than the closing price on the
date of the  respective  transaction  resulted  in a  charge  to  operations  of
approximately  $24,000.  The Company  relied upon Section 4(2) of the Securities
Act of 1933, as amended,  for an exemption from registration of these shares and
no underwriter was used in this transaction.

In August 2004,  the Company  issued 29,746 shares of  restricted,  unregistered
common stock in payment of approximately  $9,170 in accrued dividends payable on
the Company's  outstanding  Series B Preferred  Stock for the quarter ended June
30, 2004. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.



                                       20



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note N - Common Stock Transactions - Continued

Calendar 2004 Transactions - continued

On  October  19,  2004,  the  Company  issued  1,111,112  shares of  restricted,
unregistered  common  stock to acquire  certain  assets  valued at an  aggregate
$500,000. The assets consist principally of equipment (approximately  $134,000),
inventory  (approximately  $89,500)  and patents  and a covenant  not-to-compete
(approximately $276,500).

In November 2004,  the Company issued 53,908 shares of restricted,  unregistered
common stock in payment of approximately  $9,170 in accrued dividends payable on
the Company's  outstanding  Series B Preferred  Stock for the quarter ended June
30, 2004. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

Calendar 2005 Transactions

Between  January 1, 2005 and June 30,  2005,  the  Debenture  Holder  elected to
convert an aggregate $25,000,  through a separate  transactions,  in outstanding
Debenture  principal  into  registered  common stock.  This election  caused the
Company  to issue  750,000  shares  of  common  stock to the  Debenture  Holder.
Additionally,  pursuant to the contract terms, the Debenture Holder concurrently
exercised a portion of the outstanding Warrant to purchase 250,000 shares of the
Company's common stock for gross proceeds of $250,000.

On May 6, 2005 and June 21,  2005,  the Company  authorized  the  issuance of an
aggregate 14,000,000 shares into the A designated escrow account for the purpose
of  facilitating  future  conversions of the  outstanding  Debenture into common
stock in conjunction with the exercise of the outstanding  Warrants.  Subsequent
to June 30, 2005, the Debenture Holder, in 4 separate  transactions,  was issued
an aggregate  5,824,758  shares for the  conversion  of an aggregate  $40,000 in
Convertible Debenture and the exercise of 400,000 Warrants at an aggregate price
of $400,000.

In February 2005,  the Company issued 55,608 shares of restricted,  unregistered
common stock in payment of approximately  $9,170 in accrued dividends payable on
the  Company's  outstanding  Series B  Preferred  Stock  for the  quarter  ended
December 31, 2004. The Company relied upon Section 4(2) of the Securities Act of
1933,  as amended,  for an exemption  from  registration  of these shares and no
underwriter was used in this transaction.

In July and August  2005,  the Company  issued an  aggregate  416,666  shares of
restricted, unregistered common stock in 2 separate transactions for the payment
of  various  consulting  fees.  The  Company  relied  upon  Section  4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in these transactions.

In July 2005, the Company  issued  166,666  shares of  restricted,  unregistered
common stock as  additional  compensation  to the  Company's  Director of Dealer
Direct  Sales.  This  transaction  was valued at  approximately  $17,333,  which
approximated  the closing price of the Company's common stock on the transaction
date.  The Company  relied upon Section 4(2) of the  Securities  Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.




                                       21



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note N - Common Stock Transactions - Continued

Calendar 2005 Transactions - continued

In August 2005, the Company  issued  250,000 shares of restricted,  unregistered
common  stock for the payment of loan  origination  costs in  connection  with a
$500,000  Loan from an  existing  shareholder.  This  transaction  was valued at
approximately  $24,000,  which  approximated  the closing price of the Company's
common stock on the  transaction  date.  The Company relied upon Section 4(2) of
the Securities Act of 1933, as amended,  for an exemption from  registration  of
these shares and no underwriter was used in this transaction.

In August and September  2005, the Company  issued  84,053,  105,400 and 113,212
shares of  restricted,  unregistered  common  stock in payment of  approximately
$9,170 in accrued  dividends due at March 31, 2005, June 30, 2005, and September
30,  2005,  respectively,  on the  Company's  outstanding  Series  B  Cumulative
Preferred  Stock.  The Company relied upon Section 4(2) of the Securities Act of
1933,  as amended,  for an exemption  from  registration  of these shares and no
underwriter was used in this transaction.


Note O - Rental Commitments

The Company  leases its  corporate  office and  manufacturing  facility from its
controlling  stockholder under a long-term operating lease agreement.  The lease
requires a monthly payment of approximately  $5,735,  including applicable sales
taxes.  The Company is responsible for all utilities and  maintenance  expenses.
The  lease  expires  on  December  1,  2009  and  contains  a clause  that  upon
expiration,  the Company and the controlling  shareholder  shall renegotiate the
annual rental amount.

The  Company's  subsidiary,  IPE,  leases  its  manufacturing  facility  from an
unrelated third-party under a long-term operating lease agreement. This lease is
for a period of five (5) years and requires graduated monthly payments, changing
on the lease anniversary date, ranging from approximately $1,751 to $1,914, plus
the applicable  sales taxes.  The Company is  responsible  for all utilities and
maintenance expenses.  The lease expires on February 28, 2007 and may be renewed
for an additional five (5) year term at a rental rate of  approximately  $1,971,
plus applicable sales taxes for the first renewal year and 3.0% increase on each
succeeding   anniversary   date.   Total  rent  expense  under  this  lease  was
approximately  $20,752 and  $16,622,  respectively,  for each of the years ended
December 31, 2004 and 2003.

In May  2004,  the  Company  entered  into a  long-term  lease  agreement  for a
warehouse  facility  adjacent to the Company's  primary office and manufacturing
facility.  This lease is for a period of two (2) years and requires  payments of
approximately  $6,206 per month for the first 12 months and approximately $6,393
for  the  second  12  months,  plus  applicable  sales  taxes.  The  Company  is
responsible  for all utilities and maintenance  expenses.  This lease expires on
May 31, 2006.  Further,  the Company is  responsible  for any  incremental  real
estate  taxes and property  insurance  in excess of the amounts  incurred by the
landlord for the calendar year immediately preceding the execution of the lease.






                                       22



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note O - Rental Commitments - Continued

Future minimum rental payments on the above leases are as follows:

                         Year ended
                        December 31,        Amount
                        ------------      ----------
                            2005          $  166,974
                            2006             117,244
                            2007              72,643
                            2008              68,815
                            2007              68,815
                                           ---------
                           Totals          $ 494,491
                                           =========

For the respective  years ended December 31, 2004, the Company paid an aggregate
of $131,804 and $87,826 for rent under these agreements.


Note P - Income Taxes

The components of income tax (benefit) expense for the respective nine month
periods ended September 30, 2005 and 2004 are as follows:

                                                           Period from
                                                          July 31, 2001
                         Nine month      Nine month    (date of inception)
                            ended            ended            through
                        September 30,   September 30,      September 30,
                            2005             2004              2005
                        --------------  -------------   ------------------
Federal:
  Current               $            -  $           -   $                -
  Deferred                           -              -                    -
                        --------------  -------------   ------------------
                                     -              -                    -
                        --------------  -------------   ------------------
State:
  Current                            -              -                    -
  Deferred                           -              -                    -
                        --------------  -------------   ------------------
                                     -              -                    -
                        --------------  -------------   ------------------

  Total                 $            -  $           -   $                -
                        ==============  =============   ==================

As of December 31, 2004,  the Company has a net operating loss  carryforward  of
approximately  $8,150,000 to offset future  taxable  income.  Subject to current
regulations,  components  of this  carryforward  began to  expire  at the end of
Calendar  2003.  The  amount  and   availability   of  the  net  operating  loss
carryforwards  may be subject to limitations  set forth by the Internal  Revenue
Code. Factors such as the number of shares ultimately issued within a three year
look-back  period;  whether  there is a deemed  more than 50  percent  change in




                                       23



                   American Ammunition, Inc. and Subsidiaries
             Notes to Consolidated Financial Statements - Continued
                           September 30, 2005 and 2004


Note P - Income Taxes - Continued

control; the applicable long-term tax exempt bond rate; continuity of historical
business;  and  subsequent  income  of the  Company  all enter  into the  annual
computation of allowable annual utilization of the carryforwards.

The Company's  income tax expense  (benefit) for the nine months ended September
30, 2005 and 2004, respectively,  differed from the statutory federal rate of 34
percent as follows:

                                                     Nine months   Nine months
                                                        ended         ended
                                                    September 30, September 30,
                                                        2005           2004
                                                    ------------- -------------
Statutory rate applied to loss before income taxes  $  (1,062,000)$    (799,000)
Increase (decrease) in income taxes resulting from:
     State income taxes                                         -             -
     Imputed interest on derivative liability from
       warrants and convertible notes                      14,700             -
     Other, including reserve for deferred tax asset    1,062,000       799,000
                                                    ------------- -------------
       Income tax expense                           $           - $           -
                                                    ============= =============

Temporary   differences,   consisting   primarily  of  the  net  operating  loss
carryforward and statutory differences in the depreciable lives for property and
equipment,  between the financial  statement  carrying  amounts and tax bases of
assets and  liabilities  give rise to deferred tax assets and  liabilities as of
December 31, 2004 and 2003, respectively:

                                                Year ended       Year ended
                                               December 31,     December 31,
                                                   2004            2003
                                               ------------     ------------
     Deferred tax assets - long-term
       Net operating loss carryforwards        $  2,669,000     $  2,900,000
     Deferred tax liabilities - long-term
       Statutory depreciation differences          (690,000)        (250,000)
                                               ------------     ------------
                                                  1,979,000        2,650,000
     Less valuation allowance                    (1,979,000)      (2,650,000)
                                               ------------     ------------
       Net Deferred Tax Asset                  $          -     $          -
                                               ============     ============

During the years ended December 31, 2004 and 2003,  respectively,  the valuation
allowance increased (decreased) by approximately $(671,000)and $656,000.


Note Q - Subsequent Events

On  October  7,  2005,  the  Company  issued  an  aggregate  667,100  shares  of
restricted,  unregistered  common stock in exchange for the  conversion of 9,170
shares of Series B Convertible  Preferred Stock in accordance with the terms and
conditions afforded the Preferred shareholders.




                                       24




ITEM 2 - Management's Discussion and Analysis or Plan of Operation

Caution Regarding Forward-Looking Information

     Certain  statements  contained in this Quarterly Report including,  without
limitation, statements containing the words "believes", "anticipates", "expects"
and  words  of  similar  import,  constitute  forward-looking  statements.  Such
forward-looking  statements  involve known and unknown risks,  uncertainties and
other factors that may cause the actual results,  performance or achievements of
the Company,  or industry  results,  to be materially  different from any future
results,   performance   or   achievements   expressed   or   implied   by  such
forward-looking statements.

     Such factors include, among others, the following: international,  national
and local  general  economic and market  conditions:  demographic  changes;  the
ability of the Company to sustain, manage or forecast its growth; the ability of
the Company to successfully make and integrate acquisitions;  raw material costs
and availability; new product development and introduction;  existing government
regulations  and  changes  in,  or  the  failure  to  comply  with,   government
regulations;  adverse publicity;  competition; the loss of significant customers
or suppliers;  fluctuations  and  difficulty in forecasting  operating  results;
changes in business strategy or development  plans;  business  disruptions;  the
ability  to attract  and  retain  qualified  personnel;  the  ability to protect
technology; and other factors referenced in this and previous filings.

     Given these  uncertainties,  readers of this Quarterly Report and investors
are cautioned not to place undue  reliance on such  forward-looking  statements.
The Company  disclaims any  obligation to update any such factors or to publicly
announce the result of any  revisions to any of the  forward-looking  statements
contained herein to reflect future events or developments.

Restatement issues

     The September 30, 2005 financial  statements  have been restated to account
for the  derivative  liability  that was incurred in connection  with the common
stock  conversion  features and the warrants  issued with certain  notes payable
(see Notes I and J to the accompanying consolidated financial statements).

     The Company accounts for debt with embedded conversion features and warrant
issues in accordance with EITF 98-5: "Accounting for convertible securities with
beneficial  conversion features or contingency  adjustable  conversion" and EITF
No. 00-27:  "Application of issue No 98-5 to certain  convertible  instruments".
Conversion features determined to be beneficial to the holder are valued at fair
value and recorded to additional  paid in capital.  The Company  determines  the
fair value to be ascribed to the detachable warrants issued with the convertible
debentures  utilizing  the  Black-Scholes  method.  Any  discount  derived  from
determining the fair value to the debenture  conversion features and warrants is
amortized  to financing  cost over the life of the  debenture.  The  unamortized
discount, if any, upon the conversion of the debentures is expensed to financing
cost on a pro rata basis.

     Debt issues with the  variable  conversion  features are  considered  to be
embedded   derivatives   and  are  accountable  in  accordance  with  FASB  133;
"Accounting for Derivative  Instruments and Hedging Activities".  The fair value
of the embedded derivative is recorded to derivative  liability.  This liability
is required to be marked each reporting  period.  The resulting  discount on the
debt is amortized to interest expense over the life of the related debt.



                                       25




Overview

     We were  incorporated  on  February 1, 2000 in the State of  California  as
FirsTelevision.com.  We  subsequently  changed our  corporate  name to FBI Fresh
Burgers International which unsuccessfully marketed a business plan concept of a
national "fast food" restaurant chain.

     American  Ammunition,   Inc.  is  a  holding  company  with  two  operating
subsidiaries: F&F Equipment, Inc. and Industrial Plating Enterprise Co.

     F&F Equipment,  Inc. was  incorporated on October 4, 1983 under the laws of
the State of  Florida.  The  company  was  formed to engage  principally  in the
"import,  export,  retail & wholesale of firearms equipment,  ammunition & other
devices and for the purpose of transacting any and/or all lawful  business." F&F
conducts   its  business   operations   under  the  assumed  name  of  "American
Ammunition."

     In June 2002, American  Ammunition,  Inc. formed a wholly owned subsidiary,
Industrial  Plating  Enterprise Co., which started  production on June 14, 2002.
Industrial   Plating  is  a  fully   licensed   and   approved   electrochemical
metallization  facility with  significant  capacity for  processing  our line of
projectiles   as  well  as  other   products   and  services   while   employing
environmentally sound water conservation and proven waste treatment techniques.

     During the third quarter of 2003, the Company's operations  experienced the
negative  impact of a lower than  anticipated  or budgeted  purchases  by Elliot
Brothers,  a significant  customer.  However,  during this same time period, the
Company has entered into a strategic  alliance with Israel  Military  Industries
(IMI), an entity owned by the State of Israel, for the cross-production and sale
of various small arms ammunition. This alliance is anticipated to greatly expand
the Company's  catalog of products and assist in utilizing  existing  production
capacity.  While this  relationship has not generated the initially  anticipated
volumes, management remains positive on this relationship.

     In prior periods,  the Company executed a private  labeling  agreement with
Century  International Arms, Inc. (Century).  Under this agreement,  the Company
was to produce its standard  catalog of small arms ammunition plus one specialty
small arms  cartridge to  Century's  specifications  for  packaging in Century's
designated  labeling.  This agreement required no modifications to the Company's
production  line and did not require the addition of  supplemental  personnel or
equipment.  The Company made an initial shipment under this agreement to Century
during  December 2003.  Virtually  immediately,  the Company began to experience
problems with Century  regarding  Century's  compliance  with their  performance
criteria  under  this  agreement.  During  the first  quarter  of 2004,  Century
defaulted on certain  agreed-upon  payment  schedules on merchandise sold during
December 2003. In repayment of the outstanding  trade debt, the Company accepted
unscheduled  product  returns as payment of the trade debt. As a result of these
issues, the Company  recognized a charge to operations of approximately  $28,000
on its business activity with Century.  The returned  merchandise was repackaged
and is resalable  by the Company to other  customers.  As of June 30, 2004,  the
Company has cancelled this agreement,  and is contemplating  litigation  against
Century for breach of contractual obligations under this agreement.

     Additionally,  the Company has been awarded  three (3)  separate  contracts
from  various  departments  of the U. S.  Government.  Each  contract  is for an
initial term of one year  (commencing  between  April 24, 2003 and September 30,
2003)  with four (4)  successive  individual  one-year  extension  options.  The
contracts,  which  remain  in  force as of  September  30,  2004 and  subsequent
thereto) are summarized as follows:

Contract 1:    U. S. Department of State. Minimum annual volume of approximately
               100,000 rounds of military grade small arms  ammunition.  Maximum
               annual volume of approximately  5,000,000 rounds.  Maximum volume



                                       26




               may be increased at the discretion of the Contracting Officer and
               respective  utilization  requirements.  The Company has  received
               firm  orders  for  2,265,000  rounds  of  ammunition  under  this
               contract  and  has  approximately   1,265,000  rounds  ready  for
               shipment.  The ammunition  under this contract will be subject to
               the strategic alliance with Israel Military Industries (IMI). The
               Company  has applied for and  received an  engineering  change to
               allow  for the  substitution  of  Company  manufactured  items in
               substitution for the components originally to be supplied by IMI.

Contract 2:    U. S.  Department  of  Energy.  This  contract  covers  seven (7)
               separate products in the Company's  standard catalog of products.
               The U. S.  Department  of  Energy is  obligated  to  purchase  an
               aggregate of 4,549,000 rounds of ammunition under this contract.

Contract 3:    U. S. Department of Homeland Security.  This contract covers four
               (4) separate  products being introduced to the Company's  catalog
               through  the   strategic   alliance  with  IMI  and  requires  no
               modifications to the Company's production facilities or additions
               to the labor force.  The minimum annual volume is 1,000 rounds of
               each product and a maximum  annual volume of 9,600,000  rounds of
               two  (2)  products  and  36,000,000  of  the  remaining  two  (2)
               products.  The Company has shipped all first article samples,  as
               defined in the contract, and has received favorable feedback on a
               20,000  round  shipment  during the first  quarter of 2004.  Full
               scale  shipments are  anticipated  to commence  during the second
               quarter of 2004.  The Company  has  applied  for and  received an
               engineering  change  to allow  for the  substitution  of  Company
               manufactured items in substitution for the components  originally
               to be supplied by IMI.

     The Company  remains in  negotiation  for the  issuance of purchase  orders
against these  contracts and continues to prepare bids on other  contracts  from
these and other U. S. Governmental agencies.

     During  the  first  quarter  of  2004,  the  Company   commenced  a  direct
solicitation program for its "dealer direct" sales program. As this endeavor has
received a very positive initial response from the qualified retail resellers of
the Company's  product,  the  announcement  of this program had a  significantly
detrimental  impact on the Company's  relationship  with wholesale  distributors
and, accordingly, had a significant negative impact on first quarter 2004 sales.
The Company continues to experience increases in customer demand, order size and
reorder quantities in this program by smaller "single store"  owner/operators of
retail  outlets  selling the  Company's  products.  It is  anticipated  that the
overall  Calendar 2004 sales volume through the "dealer direct" program may well
equal or exceed the sales volumes  generated by wholesale  distributors in prior
years.

Results of Operations

Nine months  ended  September  30,  2005  compared  with the nine  months  ended
September 30, 2004

     During the nine months ended  September 30, 2005, we experienced  aggregate
net  revenues  of  approximately   $2,233,336,   as  compared  to  approximately
$1,712,280  during the  comparable  period ended  September 30, 2004. The second
quarter of 2005  profiles  comparably to the same quarter of 2004 with net sales
of  approximately  $378,000 versus  $862,000.  During the third quarter of 2005,
management  elected to suspend production for a period of time to facilitate the
qualification of the production facility for contracting  proposals with various
U. S. Military  channels and/or to provide qualified  subcontract  production to
other prime  contractors on U. S. Military  contracts.  This situation  caused a
significant  decline in  production  and,  accordingly,  sales  during the third
quarter  of 2005.  Management  is of the  opinion  that  these  actions  will be
fruitful in future periods.



                                       27




     During  the  first  quarter  of  2004,  the  Company   commenced  a  direct
solicitation program for its "dealer direct" sales program. As this endeavor has
received a very positive initial response from the qualified retail resellers of
the Company's  product,  the  announcement  of this program had a  significantly
detrimental  impact on the Company's  relationship  with wholesale  distributors
and, accordingly, had a significant negative impact on first quarter 2004 sales.

     The Company  continues to experience  high demand for small arms ammunition
from both the retail  channel market and domestic and foreign  governments.  The
Company has identified  certain  production  issues which has inhibited the full
realization  of existing  product  demands  and has begun to take the  necessary
steps to add specific machinery to counteract these issues.

     Through  September  30,  2005,  and  subsequent  thereto,  we  continue  to
experience negative trends off of our standard production costs for material and
labor due to difficulties in training new employees,  adding new products to our
catalog and lower than expected orders due to uncontrollable  delays in ordering
by  various U. S.  Governmental  entities.  Further,  as  previously  discussed,
management  invested   considerable  time  and  resources  into  qualifying  the
production  facility  for U. S.  Department  of Defense  orders  and/or  being a
participant with other prime  manufacturers  of small-arms  ammunition for U. S.
Military  contracts.  This effort involved shutting down production for a period
of time;  however,  management  is of the  opinion  that  future U. S.  Military
contracts will be obtained as a result of this effort.

     Management remains of the opinion that the production labor force is stable
and able to  maintain a constant  standard  of quality  for future  periods.  We
continue  to  experience  considerable  variable  costs in the area of  material
consumption and direct labor.

     For the nine month periods ended  September 30, 2005 and 2004, we generated
a  negative  gross  profit  of  approximately  $(1,787,000),  or  (80.02%),  and
approximately  $(723,000),  or (42.21%).  Based on orders  received and products
shipped during the first six months of 2005 and our ongoing  conversations  with
various  customers,  management  continues to believe that the Company should be
able to  generate  a  positive  gross  profit  in  future  periods  based on our
estimated backlog going into the 4th quarter of approximately $3,000,000.

     We experienced  nominal research and development  expenses of approximately
$2,600 and $8,300, respectively,  during the respective nine month periods ended
September  30,  2005 and 2004,  principally  related to  refinements  in and the
expansion of our product line.

     During the first nine months of 2005 and 2004,  we  expended  approximately
$162,000 and $368,000,  respectively,  in  advertising  and marketing  expenses,
principally  in developing  and promoting our retail dealer direct  program.  We
anticipate  to continue our  marketing  efforts in this area in future  periods;
however,  the  volume  and  frequency  of  our  expenditures  may  fluctuate  as
management allocates available capital to these efforts.

     Other  general  and  administrative  expenses  increased  by  approximately
$64,000 from approximately $846,000 for the nine months ended September 30, 2005
as compared to  approximately  $910,000 for the nine months ended  September 30,
2004. These increases are not identifiable by one specific area; however, relate
to general corporate expenses,  office and administrative wages and salaries and
other related office overhead.

     Included in our results of operations for the first nine months of 2005 and
2004 are certain  non-cash  expenditure  charges to operations of  approximately
$198,000 and $356,000 for compensation expense related to common stock issuances
at less than "fair value".  The  calculation  of these  charges  result from our
issuing common stock for either cash or services at valuations below the closing
quoted  market  price of our common  stock and either the cash  received  or the
value of the services provided to us by third parties.



                                       28




     We recognized a net loss of approximately $(3,167,000) and $(2,349,000) for
the  respective   nine  month  periods  ended   September  30,  2005  and  2004,
respectively,  or approximately $(0.04) and $(0.03) per share in each respective
period.

Nine months  ended  September  30,  2004  compared  with the nine  months  ended
September 30, 2003.

     During the nine and three months ended  September 30, 2004, we  experienced
net revenues of approximately $1,712,000 and $862,000, respectively, as compared
to  approximately  $1,216,000  and $317,000 for the same  respective  periods of
2003.

     During  the  first  quarter  of  2004,  the  Company   commenced  a  direct
solicitation program for its "dealer direct" sales program. As this endeavor has
received a very positive initial response from the qualified retail resellers of
the Company's  product,  the  announcement  of this program had a  significantly
detrimental  impact on the Company's  relationship  with wholesale  distributors
and, accordingly, had a significant negative impact on first quarter 2004 sales.
The Company  continues to experience  significant  increases in customer demand,
order size and reorder  quantities  in this  program by smaller  "single  store"
owner/operators of retail outlets selling the Company's products.

     During  November 2004, the Company  qualified its 1,000th dealer under this
program for direct sales and it is  anticipated  that the overall  Calendar 2004
sales volume  through the "dealer  direct"  program may well equal or exceed the
sales volumes generated by wholesale distributors in prior years.

     We experienced costs of goods sold of approximately $2,435,000 for the nine
months ended September 30, 2004 as compared to approximately  $2,209,000 for the
nine  months  ended   September   30,  2003.   Included  in  these  amounts  are
approximately $524,000 and $495,000,  respectively,  for depreciation expense on
manufacturing equipment and leasehold improvements on our production facility.

     Management is of the opinion that the production  labor force is stable and
able to  maintain  a  constant  standard  of  quality  for  future  periods.  We
experience variable costs in the area of material consumption and direct labor.

     These  depreciation  levels are  anticipated  to remain fairly  constant as
compared  to the first  quarter of 2004.  Management  has  placed on order,  and
placed initial deposits on, new manufacturing  equipment to automate the product
packaging process and to add new quality  assurance  equipment on the production
line. These commitments aggregate  approximately $450,000, of which the majority
has been expended through September 30, 2004.

     Management,  at this time,  does not  anticipate  any  further  significant
capital equipment acquisitions.

     Further,  the addition of the Industrial  Plating  Enterprise Co. equipment
during  2003  allows us to produce  certain  components  which  were  previously
outsourced to unrelated third parties.

     For the nine month periods ended September 30, 2004 and 2003, respectively,
we have  generated  a negative  gross  profit of  approximately  $(723,000),  or
(42.21%), and approximately $(993,000), or (81.66%).

     As previously reported,  our research during the second quarter of 2004 has
revealed  that the various  governmental  agencies  which have  issued  purchase
contracts to us either purchased large quantities during the last 60 days of the
Federal   Government's  year  ended  September  30,  2003  or  are  experiencing
transitional  purchasing  problems or issues  surrounding the  reorganization of
various  agencies  into the  Department of Homeland  Security,  with the related



                                       29




issues of Congressional appropriations for funding the necessary expenditures of
these  reorganized  agencies.  The  actions  of the third  quarter  proved  this
research to be correct and we received  several  purchase  order releases on our
contract with the Department of Homeland  Security.  The timing of Congressional
approval of the related appropriation bills to fund the various executive branch
departments  of the United States of America  continues to impact the timing and
release of purchase orders under our contracts as previously discussed.

     We continue  to  anticipate  that with the  fulfillment  of the  government
contracts discussed above,  continually expanding retail consumer demand for our
product line, lower production costs being experienced from internally generated
plating  activities  and  adequate  liquidity,  we will be  able to  generate  a
positive  gross profit in future  periods.  Further,  based on  production  cost
information  developed during the 4th quarter of 2002 and further refined during
2003,  management  has  developed a new model for the pricing of its products to
its customers. It is anticipated that this model will allow management to better
manage expense levels, control labor costs and maximize revenue opportunities.

     We had minimal costs allocated to research and development  expenses during
either of the quarters ended September 30, 2004 and 2003.

     Through  the  nine  months   ending   September   30,  2004,   we  expended
approximately  $368,000 in advertising  and marketing  expenses,  principally in
developing  and promoting our retail  dealer  direct  program.  We anticipate to
continue our  marketing  efforts in this area in future  periods;  however,  the
volume and frequency of our expenditures  may fluctuate as management  allocates
available capital to these efforts.

     Other  general  and  administrative  expenses  increased  by  approximately
$57,000 from approximately $789,000 for the nine months ended September 30, 2003
as compared to  approximately  $846,000 for the nine months ended  September 30,
2004. These increases are not identifiable by one specific area; however, relate
to general corporate expenses,  office and administrative wages and salaries and
other related office overhead.

     Included in our results of operations for the first nine months of 2004 are
certain non-cash expenditure charges to operations of approximately $356,000 for
compensation  expense  related  to common  stock  issuances  at less than  "fair
value".  The  calculation  of these charges result from our issuing common stock
for either cash or services at valuations  below the closing quoted market price
of our common stock (as discounted,  as applicable) and either the cash received
or the value of the services  provided to us by third parties.  During  Calendar
2003, we experienced a charge of  approximately  $94,000 for the amortization of
the Beneficial  Conversion  Feature Discount on our Preferred Stock. This charge
results  from the  difference  between the closing  quoted  market  price on our
common stock and the  equivalent  converted  price of our Mandatory  Convertible
Preferred Stock which was sold and converted during 2003.

     We recognized a net loss of approximately $(2,350,000) and $(2,662,000) for
the  respective   three  month  periods  ended  September  30,  2004  and  2003,
respectively, or $(0.03) and $(0.04) per share.

Liquidity And Capital Resources

     As of  September  30,  2005,  December  31, 2004 and  September  30,  2004,
respectively,  we had working capital of approximately $(265,000),  $872,000 and
$960,000. Our working capital position continues to fluctuate based on our sales
volume,  collections on our trade accounts receivable and cash received from the
contractually  mandatory  exercise  of our  outstanding  warrant  related to our
convertible debenture.  Further, we anticipate that we have sufficient inventory
levels to  support  our  retail  dealer  direct  program  and our  existing  and
anticipated U. S. Government contracts.



                                       30




     We have used cash in operating activities of approximately $(1,663,000) and
$(728,000)  during the nine month  periods  ended  September  30, 2005 and 2004,
respectively.

     We  anticipate  that our  liquidity  position  will  continue to improve as
management is of the opinion that,  with the current  changes to our  production
capacity,  the  Company  will be in a position to better  support  all  existing
orders and accept  existing  inquiries  which have previously been denied due to
the lack of production capacity and liquidity.

     During the nine months ended September 30, 2005 and 2004, respectively,  we
added   approximately   $111,000  and  $436,000  in  new  equipment.   Based  on
communicated  future  demand for our products,  we have  instituted a program to
expand our production capacity through the addition of additional equipment from
the open market.  The equipment  ultimately to be added is fully  dependent upon
the  Company's  cash  position,  the  availability  of either new equity or debt
capital and the  ultimate  realization  of  communicated  future  product  sales
demand.  Management is of the opinion that sufficient demand will be present, as
supported by new product development and increased product marketing efforts, to
justify this expansion. However, we may not be able to obtain additional funding
or, that such funding,  if available,  will be obtained on terms favorable to or
affordable by us.

Convertible Debenture

     The Company entered into a Securities Purchase Agreement with La Jolla Cove
Investors,  Inc. ("La Jolla") on October 4, 2002 for the sale of (I) $250,000 in
convertible  debentures and (ii) warrants to buy 30,000,000 shares of our common
stock.  On March 13, 2003 and May 6, 2003,  La Jolla  advanced an  aggregate  of
$350,000 to our company which such funding was  allocated  towards the principal
balance of our convertible debentures.

     As of  September  30,  2005,  the  outstanding  balance on the  convertible
debenture is approximately $241,365 and we have approximately 2,413,650 warrants
outstanding.

     The  debentures  bear  interest  at 8%,  mature on June 30,  2007,  and are
convertible  into our common stock,  at the selling  stockholder's  option.  The
convertible  debentures are convertible  into the number of our shares of common
stock equal to the principal amount of the debentures being converted multiplied
by 11,  less the  product of the  conversion  price  multiplied  by 10 times the
dollar  amount  of the  debenture.  The  conversion  price  for the  convertible
debentures is the lesser of (I) $1.00 or (ii) seventy six percent of the average
of the five lowest volume weighted average prices during the twenty (20) trading
days  prior  to the  conversion.  Accordingly,  there is in fact no limit on the
number of shares into which the  debenture  may be  converted.  However,  in the
event that our market price is less than $.30, we will have the option to prepay
the debenture at 125% rather than have the debenture converted. In addition, the
selling  stockholder is obligated to exercise the warrant  concurrently with the
submission  of a conversion  notice by the selling  stockholder.  As of June 30,
2005,  the warrant is exercisable  into  2,413,650  shares of common stock at an
exercise price of $1.00 per share.

     In December 2004, we entered into an addendum to the convertible  debenture
and warrant whereby the Company agreed to the following:

     *    the discount multiplier was reduced from eighty percent to seventy six
          percent;
     *    within five  business  days after this  registration  statement  being
          declared  effective,  La  Jolla is  required  to  submit  a  debenture
          conversion  in the  amount of  $10,000  and every  ten  business  days
          thereafter La Jolla shall submit three additional debenture conversion
          in the amount of $10,000 each;



                                       31




     *    within five  business  days after this  registration  statement  being
          declared effective, La Jolla shall wire $400,000 to us as a prepayment
          towards the exercise of its warrant; and
     *    immediately  following  the  sale of all  shares  held by La  Jolla in
          connection with the debenture  conversions in the aggregate  amount of
          $40,000,  La Jolla shall wire  $275,000 to us as a prepayment  towards
          the exercise of its warrant and shall submit a debenture conversion in
          the amount of $6,250 on the first business day of each month until the
          debenture is no longer outstanding.

     LaJolla  has  contractually  agreed to  restrict  its ability to convert or
exercise  its  warrants  and  receive  shares of our common  stock such that the
number of shares of common  stock held by them and their  affiliates  after such
conversion  or exercise  does  exceed  4.9% of the then  issued and  outstanding
shares of common stock.

     Due to the contractually agreed mandatory conversion of this Debenture, the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

     As  the  warrant  is   non-detachable   from  the  Debenture  and  requires
simultaneous exercise upon conversion of the Debenture, no value was assigned to
the issued  warrant.  Upon exercise of the warrant,  the Company will record the
issuance of the underlying  shares as a new issuance of common stock on the date
of each respective exercise.

     On various dates through December 31, 2003, the Debenture Holder elected to
convert an aggregate $208,635, through 24 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 4,561,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 2,086,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $2,086,350.

     On  various  dates  between  January 1, 2004 and  December  31,  2004,  the
Debenture  Holder elected to convert an aggregate  $150,000,  through 6 separate
transactions,  in outstanding  Debenture principal into registered common stock.
This election  caused the Company to issue  4,900,000  shares of common stock to
the  Debenture  Holder.  Additionally,  pursuant  to  the  contract  terms,  the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase  1,500,000  shares of the Company's  common stock for gross proceeds of
$1,500,000.  As of December  31, 2004,  an aggregate of 1,000,000  shares of the
Company's  common  stock have been  issued by the  Company and are being held in
escrow by the Company's  counsel  pending receipt of the final $150,000 from the
Debenture Holder.

     Between  January 1, 2005 and  September  30,  2005,  the  Debenture  Holder
elected to convert an aggregate  $25,000,  through a separate  transactions,  in
outstanding  Debenture  principal into  registered  common stock.  This election
caused the  Company to issue  750,000  shares of common  stock to the  Debenture
Holder.  Additionally,  pursuant to the contract  terms,  the  Debenture  Holder
concurrently  exercised a portion of the outstanding Warrant to purchase 250,000
shares of the Company's common stock for gross proceeds of $250,000.



                                       32




     On May 6, 2005 and June 21, 2005, the Company authorized the issuance of an
aggregate 14,000,000 shares into the A designated escrow account for the purpose
of  facilitating  future  conversions of the  outstanding  Debenture into common
stock in conjunction with the exercise of the outstanding  Warrants.  Subsequent
to June 30, 2005, the Debenture Holder, in 4 separate  transactions,  was issued
an aggregate  5,824,758  shares for the  conversion  of an aggregate  $40,000 in
Convertible Debenture and the exercise of 400,000 Warrants at an aggregate price
of $400,000.


ITEM 3 - Controls and Procedures

(a)  Evaluation of Disclosure Controls and Procedures

     Under  the  supervision  and  with  the  participation  of our  management,
including our principal  executive officer and principal  financial officer,  we
conducted an evaluation of our disclosure controls and procedures,  as such term
is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of
1934, as amended (Exchange Act), for the quarter ended September 30, 2005. As of
the end of the period  covered by this report,  management,  including the chief
executive officer and chief financial officer evaluated the effectiveness of the
design and operation of our disclosure  controls and procedures.  Based upon and
as of the date of that evaluation, our CEO and CFO concluded that the disclosure
controls and procedures were effective

(b)  Changes in Internal Controls

     There were no significant changes (including corrective actions with regard
to significant  deficiencies  or material  weaknesses) in our internal  controls
over financial  reporting that occurred  during the quarter ended  September 30,
2005 that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.

(c)  Findings

     In light of the restatements to the financial  statements  disclosed above,
caused,  in part, by a failure in the Company's  internal control over financing
reporting  due to the  limitations  in the  Company's  accounting  resources  to
identify  and  react  in  a  timely  manner  to   non-routine,   complex  and/or
transactions  originated by other parties on the  Company's  behalf,  as well as
gaining an adequate  understanding  of the disclosure  requirements  relating to
these types of transactions,  we feel that the existing  controls and procedures
were and remain  effective.  Because of said  controls,  which  resulted  in the
review,  discovery and disclosure by amendment of filings to adequately disclose
required information,  management also concludes that by requiring  supplemental
reviews of financing transactions that its existing controls and procedures will
be more effective.



                           PART II - OTHER INFORMATION


ITEM 1 - Legal Proceedings

     The Company may become involved in various claims and legal actions arising
in the ordinary course of business.  In the opinion of management,  the ultimate
disposition  of these  matters will not have a material  adverse  impact  either
individually  or  in  the  aggregate  on  consolidated  results  of  operations,
financial position or cash flows of the Company.






                                       33




ITEM 2 - Recent Sales of Unregistered Securities and Use of Proceeds

     In July 2005, the Company issued 166,666 shares of restricted, unregistered
common stock as additional  compensation to Paul Goebel,  the Company's Director
of Dealer Direct Sales.  This transaction was valued at  approximately  $17,333,
which  approximated  the  closing  price of the  Company's  common  stock on the
transaction  date. The Company relied upon Section 4(2) of the Securities Act of
1933,  as amended,  for an exemption  from  registration  of these shares and no
underwriter was used in this transaction.

     In  August  2005,   the  Company   issued  250,000  shares  of  restricted,
unregistered  common  stock  for  the  payment  of  loan  origination  costs  in
connection with a $500,000 Line of Credit facility.  This transaction was valued
at approximately  $24,000, which approximated the closing price of the Company's
common stock on the  transaction  date.  The Company relied upon Section 4(2) of
the Securities Act of 1933, as amended,  for an exemption from  registration  of
these shares and no underwriter was used in this transaction.

     In August and  September  2005,  the  Company  issued  84,053,  105,400 and
113,212  shares  of  restricted,   unregistered   common  stock  in  payment  of
approximately  $9,170 in accrued dividends due at March 31, 2005, June 30, 2005,
and September 30, 2005,  respectively,  on the  Company's  outstanding  Series B
Cumulative  Preferred  Stock.  The  Company  relied  upon  Section  4(2)  of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.


ITEM 3 - Defaults on Senior Securities

   None


ITEM 4 - Submission of Matters to a Vote of Security Holders

   None


ITEM 5 - Other Information

   None


ITEM 6 - Exhibits and Reports on Form 8-K

(a) The exhibits required to be filed herewith by Item 601 of Regulation S-B, as
described in the following index of exhibits are incorporated herein.

Exhibit      Descriptions
---------   -----------------------
31.1        Certification pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
32.1        Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002.

(b) Reports on Form 8-K

     None











                                       34




                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                            American Ammunition, Inc.




Dated: bctober 19, 2007        /s/ Andres F. Fernandez
      -------------------      -----------------------------------------
                               Andres F. Fernandez
                               President, Chief Executive Officer
                               Chief Financial Officer and Director






















                                       35